FDA vaccine head will step down in April after string of controversial decisions

The top vaccine and biologics drug official in the U.S. Food and Drug Administration will step down in April. The agency made ...

Biotech firm stocks rise on FDA vaccine head’s exit

Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine chief, Dr. Vinay Prasad. Prasad, the head of the FDA’s division of vaccines and ...

Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn

Investors who closely watch the healthcare sector are keeping an eye on Moderna (NASDAQ:MRNA) as its shares are up 12% over ...

COVID-19 vaccine maker Novavax swings to profit as sales climb

Novavax Inc. NVAX shares are up on Thursday following the company’s announcement of its fourth-quarter and full-year 2025 ...

Moderna reaches vaccine settlement, GitLab's guidance disappoints

Yahoo Finance anchor Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. US stock ...
Hosted on MSN

MRNA vs NVAX: Which vaccine stock is Wall Street more bullish on right now?

・Analysts see greater upside in Novavax, while Moderna carries a ‘Hold’ rating despite stronger gains over the past year. ・Moderna was in focus after updated cancer vaccine data, while Novavax drew ...
Business Insider

Valneva Provides Update on Chikungunya Vaccine IXCHIQ®

Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and commercial attractiveness Saint Herblain (France), January 19 ...